التفاصيل البيبلوغرافية
| العنوان: |
Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study. |
| المؤلفون: |
Giovanni Manfredi Assanto ,, Matteo Totaro, Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile |
| المصدر: |
Mediterranean Journal of Hematology and Infectious Diseases, Vol 15, Iss 1 (2023) |
| بيانات النشر: |
PAGEPress Publications, 2023. |
| سنة النشر: |
2023 |
| المجموعة: |
LCC:Diseases of the blood and blood-forming organs |
| مصطلحات موضوعية: |
B-cell malignancies, COVID-19, tixagevimab-cilgavimab, Pre-exposure prophylaxis, Diseases of the blood and blood-forming organs, RC633-647.5 |
| الوصف: |
Severe Acute Respiratory Syndrome CoronaVirus‐2 (SARS‐CoV‐2) infection can result in different clinical manifestations (COVID-19), starting from asymptomatic disease to life threatening respiratory insufficiency. Onco-haematologic patients are at higher risk to develop severe COVID-19. In particular, patients affected by lymphoproliferative diseases, given the impaired cell-mediated and antibody-mediated immunity and treatment toxicity, develop more often a symptomatic and a more serious disease of Covid-19. Various therapeutic and prophylactic agents are being used against COVID‐19 such as antiviral drugs, vaccines and antiviral S‐protein monoclonal antibodies. Pre-exposure prophylaxis with AZD442/Evusheld (tixagevimab-cilgavimab) may be a complementary strategy to decrease the incidence or severity of COVID-19 for patients with B-cell malignancies. Tixagevimab-cilgavimab is a combination of two monoclonal antibodies that bind SARS-CoV-2 spike protein and inhibits the attachment to the surface of cells, preventing viral entry in the cell and COVID-19 development. In the setting of hematology real-life, few data are available on the impact of pre-exposure prophylaxis, given the multiple factors involved in the clinical behavior of SARS-CoV-2 . Our aim was to evaluate the clinical benefit and the safety of this strategy at our center. |
| نوع الوثيقة: |
article |
| وصف الملف: |
electronic resource |
| اللغة: |
English |
| تدمد: |
2035-3006 |
| Relation: |
http://www.mjhid.org/index.php/mjhid/article/view/5415; https://doaj.org/toc/2035-3006 |
| DOI: |
10.4084/MJHID.2023.061 |
| URL الوصول: |
https://doaj.org/article/2333e79f73004c0eb7baff70540cfd15 |
| رقم الانضمام: |
edsdoj.2333e79f73004c0eb7baff70540cfd15 |
| قاعدة البيانات: |
Directory of Open Access Journals |
Full Text Finder